Senolytics alleviate cyclophosphamide-induced premature ovarian insufficiency by eliminating senescent cells
European Journal of Histochemistry · 21.04.2026 · 70 (2)
DOI: 10.4081/ejh.2026.4537 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Histochemistry, online erschienen am 21.04.2026. Verfasst von Huina Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing. Hauptthemen laut MEDLINE: Cyclophosphamide, Primary Ovarian Insufficiency, Cellular Senescence, Quercetin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Alkylating agents, particularly cyclophosphamide (CY), are known for their high toxicity, which can lead to iatrogenic premature ovarian insufficiency (POI) and infertility in young cancer survivors. Currently, effective prevention and treatment strategies remain limited. Given that chemotherapy induces cellular senescence, we investigated the therapeutic potential of dasatinib (D) and quercetin (Q), a senolytic combination known to eliminate senescent cells. Using a CY-induced murine model of ovarian injury, we found that CY treatment increased the accumulation of senescent cells in the ovaries. The resulting senescence-associated secretory phenotype (SASP) led to a deterioration of the ovarian microenvironment, characterized by increased follicular atresia and a decline in follicle quantity, ultimately culminating in POI. Our findings demonstrate that DQ therapy effectively mitigated CY-induced damage by clearing senescent cells and reducing SASP secretion. Clinically, DQ administration restored sex hormone levels and regularity of the estrous cycle, resulting in an overall increase in follicle numbers across all developmental stages. Furthermore, DQ treatment significantly normalized estrous cyclicity, restoring regular cycles in 60% of the CY+DQ mice compared to only ~15% in the CY-alone group (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing.
Zitieren
APA
Su, H., Ma, R., Su, D., Tan, C., Zhu, Y., & Yang, X. (2026). Senolytics alleviate cyclophosphamide-induced premature ovarian insufficiency by eliminating senescent cells. European Journal of Histochemistry, 70(2). https://doi.org/10.4081/ejh.2026.4537
Vancouver
Su H, Ma R, Su D, Tan C, Zhu Y, Yang X. Senolytics alleviate cyclophosphamide-induced premature ovarian insufficiency by eliminating senescent cells. European Journal of Histochemistry. 2026;70(2). doi:10.4081/ejh.2026.4537
BibTeX
@article{Su2026,
author = {Su, Huina and Ma, Ruiqiong and Su, Dehui and Tan, Cheng and Zhu, Ye and Yang, Xin},
title = {Senolytics alleviate cyclophosphamide-induced premature ovarian insufficiency by eliminating senescent cells},
journal = {European Journal of Histochemistry},
year = {2026},
volume = {70},
number = {2},
doi = {10.4081/ejh.2026.4537}
}
EUVIMED